<DOC>
	<DOCNO>NCT01498042</DOCNO>
	<brief_summary>Stroke among disabilitating disease worldwide term number affect consequence . A relatively new well document treatment acute ischemic stroke today tPA ( tissue plasminogen activator ; call thrombolysis ) Unfortunately minority patient give treatment . The large randomise controlled trial investigate safety efficacy thrombolytic therapy treatment acute stroke include patient 80 year . In age population western world importance investigate whether treatment safe effective group . Both Sorlandet hospital Kristiansand Norway Bergen hospital administer thrombolysis select patient 80 year last year . In addition registration patient stroke register location . This lay foundation investigation . In association Bergen investigator include 77 patient 80 year treat thrombolysis . In addition investigator 85 patient treat tpa 80 year . In cohort investigator go compare outcome 2 group . In addition investigator go perform regression analysis select variable see association variable predefined outcome measure . Our outcome measure follow : mRS=6 ( death ) mRS 0-1 ( good outcome ) 3 month control . The third outcome measure developement sICH secondary tPA treatment . As definition sICH choose definition Ecass .</brief_summary>
	<brief_title>Predictors Outcome t-PA Treated Stroke .</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Patients acute ischemic stroke treat thrombolysis 80 year 01.01.200728.02.2010 predefined center . Patients acute ischemic stroke treat thrombolysis Sorlandet hospital Kristiansand 80 year defined period . Two patient exclude due miss data three month control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>